Map * Disclaimer
* Site Search * Index *
Virtual Reality and Bio Chips
much of this will move to http://ThePiedPiper.tripod.com/vr0001.htm
added 28 Oct 2000
Kurzweil: Rooting for the Machine
by Declan McCullagh
1:35 p.m. Nov. 3, 2000 PST
BETHESDA, Maryland -- Raymond Kurzweil doesn't merely predict that machine
intelligence will surpass human brains by the end of the century. He's
eagerly anticipating it.
In a Kurzweillian future, the world would become a
very strange place, where converging advances in nanotechnology,
biotechnology and computer science combine to propel humanity to its next
stage of evolution.
Why Bill Joy is Elitist, Myopic, and
Wrong By Lizard
October 30, 2000
Why the future doesn't need us.
Our most powerful 21st-century technologies - robotics, genetic engineering,
and nanotech - are threatening to
make humans an endangered species.
By Bill Joy
Charles M. Lieber Department of Chemistry, Harvard University
12 Oxford Street, Cambridge, MA 02138
Packard BioScience, DOD, and Russian Genome Project are working on this,
there also suppose to be one that IBM has been working on. Check out my
citations on Fungus and imagion what would happen if fungus is capable of
incorporating itís self into the source code of these chips or into the human
DNA source code.
Motorola, Packard Instrument Co. and Argonne to develop advanced biochip technology
ARGONNE, Ill. (June 29, 1998) -- Rapid advances in medicine, health care and
agriculture are expected from a joint-research project announced today
byMotorola Inc.,Packard Instrument Company and the U.S. Department of
Energy's Argonne National Laboratory.
July 11, 2000
Packard BioScience Announces Issuance of Key Biochip Production Patents July
Meriden, CT -- Packard BioScience Company (Nasdaq: PBSC), a worldwide leader
in the life science tools and nuclear industries, announced today the
issuance of US Patents 6,079,283 and 6,083,762 ,which together include 44
claims providing broad and fundamental coverage encompassing biochip
production by transfer of liquids through non-contact dispensing.
Packard BioScience Announces Issuance of Key Biochip Production Patents
These patents cover methods and devices for aspirating liquids and dispensing
containing biomolecules such as DNA, proteins and cells. This non-contact droplet
also known as "drop-on-demand" dispensing, is analogous to
ink-jetting technology and enables the
inexpensive production of high-quality gene chips and protein chips.
Background Q & A Biochip Commercialization Project
Motorola Inc., Packard Instrument Co., Argonne National Laboratory
What is the project's goal?
The goal is to develop and commercialize a new technology that can decode the
genetic structures of living
things thousands of times faster than existing technology. The technology
uses biochips, robots and computers to automate the massively parallel
detection of gene mutations and to simultaneously analyze the activity of
thousands of genes in healthy and diseased cells and tissues.
Who are the partners and what special capabilities does each provide?
The partners are Motorola Inc., Packard Instrument Company and the U.S.
Department of Energy's Argonne
Each brings special expertise and capabilities to the project.
The 19 inventions, which have been licensed exclusively to Motorola and
Packard, are the result of more than $10 million in research support since
1994 by the US. Department of Energy, the Defense Advanced Research Projects
Agency, the Russian Academy of Sciences, and the Russian Human Genome
Sequencing Technologies abstracts from the DOE Human Genome Program
Contractor-Grantee Workshop VI
November 9-13, 1997, Santa Fe, NM